Android app on Google Play

Cadence Pharmaceuticals, Inc. (CADX) Misses Q1 EPS by 5c; Guides Q2 Sales Below

May 3, 2012 4:36 PM EDT Send to a Friend
Get Alerts CADX Hot Sheet
Trade CADX Now!
Join SI Premium – FREE
Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) reported Q1 EPS of ($0.27), $0.05 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $8 million versus the consensus estimate of $8.93 million.

Sees Q2 2012 revenue of $10-$10.4 million, versus the consensus of $15.0 million.

For earnings history and earnings-related data on Cadence Pharmaceuticals, Inc. (CADX) click here.

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Guidance

Related Entities


Add Your Comment